Kassie Harrold is the senior vice president, chief compliance officer at Mallinckrodt Pharmaceuticals. She has responsibility for global ethics and the compliance program, including risk assessment and mitigation, hotline reporting and investigations, program monitoring and governance, and is a member of Mallinckrodt’s senior leadership team.
Ms. Harrold has more than 15 years of compliance experience in the pharmaceutical and specialty chemical industries, Ms. Harrold has assessed, implemented and managed compliance programs in a broad range of subject matter areas.
Ms. Harrold has held roles of increasing responsibility since joining Mallinckrodt Pharmaceuticals in 2013, including leading the trade compliance and business support functions and advising senior management on a broad range of business matters as the Senior Staff Liaison to the President and Chief Executive Officer. Previously, Ms. Harrold held several positions, including global compliance, litigation and employment counsel and government affairs, with Solutia Inc., the specialty chemicals spin-off of Monsanto.
Ms. Harrold holds a Bachelor of Science and Juris Doctorate Degrees from Duquesne University in Pittsburgh, Pennsylvania. She is active in the Healthcare Businesswomen’s Association (HBA), having served on the St. Louis chapter board and was selected as Mallinckrodt Pharmaceuticals’ 2016 HBA Rising Star.